Onkos Surgical Raises $15 in Series C Funding

Onkos Surgical has announced the closing of a Series C funding round at $15 million led by 1315 Capital with the participation of existing investors.

Being a leader when it comes to innovation of solutions for musculoskeletal oncology and complex orthopedic procedures, the latest investment will be used to boost the company’s research and development strategies, expanding its services, and accelerating manufacturing capabilities in order to increase the company’s revenue.

Founding partner of 1315 Capital and Onkos Surgical board member, Adele Oliva, referred to the firm’s decision to participate by stating:

“The market Onkos serves has been ripe for disruption based on the unmet clinical needs of these highly specialized surgeons and their patients. Driven by their unique purpose and highly-focused strategy, Onkos is delivering on the promise of innovation and solving clinical challenges that will lead to improved patient outcomes. With every key milestone achievement, the team demonstrates they are successfully creating a valuable and important business and we continue to be excited about the company Onkos is building.”

These efforts will allow the startup to improve conditions for studying and providing surgeon-driven and patient-inspired approaches to solve three main clinical issues when it comes to complex orthopedic procedures: infection, implant loosening, and soft tissue failures. As a result, surgeons will have a better chance to plan and implement more precise reconstructions. Patrick Treacy, Co-Founder, and CEO at Onkos Surgical said:

“Today marks another significant milestone for Onkos Surgical. Despite the challenge and the impact associated with the pandemic, we were able to demonstrate significant revenue growth while executing our innovation and commercial initiatives. From the beginning, we have never wavered on our ‘why’ – which is that we believe individuals with cancer requiring surgery deserve solutions designed specifically for them. With this additional investment, Onkos is well-positioned to accelerate our growth and deliver meaningful innovation for our surgeon customers and the patients they care for.”

According to the startup, through the most advanced innovations in virtual surgical planning, 3D modeling and printing, implant design, and workflow optimization, its personalized approach could bring better patient outcomes and experiences. To date, there are more than 350 leading medical institutions in the US that have recognized and selected the innovative Precision Orthopaedics solutions developed by Onkos Surgical.